Addus HomeCare (ADUS) vs Chemed (CHE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Chemed (CHE) has outperformed Addus HomeCare (ADUS) over the past year, gaining 15.0% versus a gain of 2.4%. Over five years, ADUS leads with a +47.1% price change compared with +16.6% for CHE. Chemed is the larger company by market cap ($6.55 billion vs $2.12 billion), about 3.1 times the size.
On valuation, Addus HomeCare trades at a lower forward P/E (15.0x vs 18.2x for Chemed). Chemed pays a dividend yielding 0.48%, while Addus HomeCare does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADUS | CHE |
|---|---|---|
| Share price | $113.27 | $501.45 |
| Market cap | $2.12B | $6.55B |
| 1-day change | +0.10% | -1.65% |
| YTD return | +5.48% | +17.20% |
| 1-year return | +2.38% | +14.99% |
| 5-year return | +47.10% | +16.58% |
| P/E ratio (TTM) | 19.84 | 25.22 |
| Forward P/E | 15.02 | 18.22 |
| EPS (TTM) | $5.71 | $19.88 |
| Dividend yield | 0.00% | 0.48% |
| Annual dividend | $0.00 | $2.40 |
| Revenue (latest FY) | — | $2.53B |
| Revenue growth (YoY) | — | +4.06% |
| Net income (latest FY) | — | $265.24M |
| Gross margin | — | 32.54% |
| Operating margin | — | 13.37% |
| Net margin | — | 10.48% |
| 52-week high | $124.44 | $557.00 |
| 52-week low | $87.95 | $365.21 |
| Distance from 52-week high | -8.98% | -9.97% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +18.37% | +13.99% |
| Average volume | 218.72K | 160.12K |
| Shares outstanding | 18.67M | 13.07M |
| Employees | 5,982 | 15,811 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Chemed is about 3.1 times larger than Addus HomeCare by market value ($6.55B vs $2.12B).
- CHE has outperformed ADUS by 12.6 percentage points over the past year.
- Chemed trades at a higher earnings multiple (25.2x vs 19.8x trailing P/E).
About Addus HomeCare
ADUS stock →Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Health Care · Medical/Nursing Services · 5,982 employees
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
ADUS vs CHE FAQ
Which is bigger, Addus HomeCare or Chemed?
Chemed (CHE) is larger, with a market capitalization of $6.55B compared with $2.12B for Addus HomeCare (ADUS).
Which stock has performed better over the past year, ADUS or CHE?
CHE returned +14.99% over the past 12 months, compared with +2.38% for ADUS (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ADUS or CHE?
ADUS has the lower trailing P/E at 19.8, versus 25.2 for CHE. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Addus HomeCare or Chemed?
Chemed pays a dividend yielding 0.48%, while Addus HomeCare does not currently pay a regular dividend.
Are Addus HomeCare and Chemed in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.